Hence activation of mTOR pathway may be a converging pathway in the pathogenesis of both SLE and LAM, which suggests that patients with SLE may be at risk of or susceptible to the development of LAM. The gene discussed is MTOR; the disease is lymphangioleiomyomatosis.